FairDeal Corporation (FDC), one of India’s leading pharmaceutical companies has received an approval from the U.S. Food and Drugs Administration (USFDA) for the company’s Abbreviated New Drug Application (ANDA) Ciprofloxacin Ophthalmic solution.

Ciprofloxacin Ophthalmic solution is a broad spectrum antibiotic, recommended for the treatment of ocular surface infections.

FDC manufactures electral, oral rehydration salt (ORS). It also manufactures bulk drugs, formulations and food products
 
Recently, the company ( FDC) had received nod for Timolol Maleate Ophthalmic Solution. Another ANDA Ofloxacin Ophthalmic solution is in the final stage of approval.

Stock of FDC closed at Rs 25, up 2.43 per cent on National Stock Exchange. The total volume of shares traded was 37,923 at the Bombay Stock Exchange.